High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer

被引:9
|
作者
Song, Li [1 ]
Xing, Aiyan [2 ]
Li, Qiuju [1 ]
Wang, Guoyun [1 ]
机构
[1] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
基金
美国国家科学基金会;
关键词
endometriosis-associated malignancy; rectal endometriosis; high-grade serous carcinoma; simultaneous primary carcinoma; ovarian cancer; ADENOCARCINOMA;
D O I
10.3389/fonc.2019.01252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometriosis is one of the most common benign gynecological diseases. It shows similar attributes to those of some fatal tumors if it is becomes malignant. These attributes include invasion, implantation, and recurrence. Epidemiological, clinicopathological, molecular biological, and genetic evidence suggest that malignancy of endometriosis, referred to as endometriosis-associated malignancy (EAM), is histologically closely related to endometriosis. Atypical endometriosis, which usually causes EAM, is considered a transitional condition from benign endometriosis to cancer. Approximately 80% of EAMs occur in the ovary and are known as endometriosis-associated ovarian cancer (EAOC). However, extragonadal endometriosis is not common, and no earlier study reported an association between malignant transformation of rectal endometriosis and high-grade serous cancer. We report a rare case of high-grade serous carcinoma resulting from rectal endometriosis and complicated with ovarian cancer. A 63-year-old Chinese woman was admitted with a complaint of abdominal distension. We diagnosed the patient with ovarian carcinoma and decided on elective cytoreductive surgery as treatment for the patient. During the surgery, we found a solid mass of diameter 12 cm in the anterior rectal wall containing sticky brown fluid. Postoperative histopathological examination revealed high-grade serous carcinoma resulting from rectal endometriosis and complicated with ovarian cancer. The patient postoperatively received 6 cycles of chemotherapy consisting of carboplatin and paclitaxel and was followed up for 1 year with no recurrence of the condition.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma
    Pugh-Toole, Morgan
    Nicolela, Anna P.
    Nersesian, Sarah
    Leung, Brendan M.
    Boudreau, Jeanette E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (02) : 210 - 226
  • [32] Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
    Hwangbo, Suhyun
    Kim, Se Ik
    Kim, Ju-Hyun
    Eoh, Kyung Jin
    Lee, Chanhee
    Kim, Young Tae
    Suh, Dae-Shik
    Park, Taesung
    Song, Yong Sang
    CANCERS, 2021, 13 (08)
  • [33] Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
    Se Ik Kim
    Hyung-Chul Lee
    Hyun-Kyu Yoon
    Hee Seung Kim
    Hyun Hoon Chung
    Jae-Weon Kim
    Noh Hyun Park
    Yong-Sang Song
    Maria Lee
    BMC Cancer, 22
  • [34] Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
    Kim, Se Ik
    Lee, Hyung-Chul
    Yoon, Hyun-Kyu
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Lee, Maria
    BMC CANCER, 2022, 22 (01)
  • [35] High-grade serous carcinoma of tubo-ovarian origin: recent developments
    Singh, Naveena
    McCluggage, W. Glenn
    Gilks, C. Blake
    HISTOPATHOLOGY, 2017, 71 (03) : 339 - 356
  • [36] Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
    Cooke, S. L.
    Ng, C. K. Y.
    Melnyk, N.
    Garcia, M. J.
    Hardcastle, T.
    Temple, J.
    Langdon, S.
    Huntsman, D.
    Brenton, J. D.
    ONCOGENE, 2010, 29 (35) : 4905 - 4913
  • [37] Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma
    Morgan Pugh-Toole
    Anna P. Nicolela
    Sarah Nersesian
    Brendan M. Leung
    Jeanette E. Boudreau
    Current Treatment Options in Oncology, 2022, 23 : 210 - 226
  • [38] Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
    Kim, Se Ik
    Jung, Minsun
    Dan, Kisoon
    Lee, Sungyoung
    Lee, Cheol
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Han, Dohyun
    Lee, Maria
    CANCERS, 2020, 12 (04)
  • [39] Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review
    Mimori Fujimori
    Toshifumi Takahashi
    Yuka Furukawa
    Atsuhiro Takanashi
    Yoshiyuki Iizawa
    Masatoshi Jimbo
    Shu Soeda
    Keiya Fujimori
    Kazuyuki Takeichi
    BMC Women's Health, 22
  • [40] miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer
    Szubert, Maria
    Nowak-Gluck, Anna
    Domanska-Senderowska, Daria
    Szymanska, Bozena
    Sowa, Piotr
    Rycerz, Aleksander
    Wilczynski, Jacek R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)